SOBRsafe, a leader in alcohol detection technology, has announced the appointment of Kris Pederson to its Board of Directors and Dr. Benjamin Sanchez as a Scientific Advisor, marking a significant step in its mission to combat alcohol misuse. Pederson, with a rich background in corporate governance at firms like EY, IBM, and PwC, will join the board on May 1, 2025, and will lead the Nominating and Corporate Governance Committee. Dr. Sanchez, appointed in February, brings scientific expertise to the table, aiming to secure federal funding and foster clinical research partnerships.
The timing of these appointments is critical, as alcohol misuse continues to pose a severe public health challenge, ranking as the fourth leading cause of preventable death in the U.S. and seventh globally. SOBRsafe's innovative transdermal sensing technology offers a groundbreaking alternative to traditional alcohol detection methods, enabling instantaneous detection through touch without the need for breath, blood, or urine samples. This technology, embodied in products like SOBRcheck for point-of-care screening and SOBRsure for continuous monitoring, has the potential to revolutionize alcohol misuse prevention across various sectors.
With Pederson's governance expertise and Dr. Sanchez's scientific acumen, SOBRsafe is well-positioned to accelerate the development and deployment of its alcohol detection solutions. These strategic appointments underscore the company's dedication to addressing the global challenge of alcohol misuse through technological innovation and strategic leadership. For more information on SOBRsafe's technology, visit https://www.sobrsafe.com.
